<DOC>
	<DOCNO>NCT02927626</DOCNO>
	<brief_summary>Clinical research Yang Yin Fu Zheng therapy HBV associate hepatocellular carcinoma base immune microenviroment.The purpose study observe efficacy routine medical care combine Yang Yin Fu Zheng therapy patient belong HBV-HCC .</brief_summary>
	<brief_title>Yang Yin Fu Zheng Therapy HBV Associated Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Confirmed stage HBVHCCⅡb、Ⅲa、Ⅲb ; 2 . Ages Eligible Study : ≤75 year old ; 3 . TCM syndrome deficiency Qi Yin ; 4 . Confirmed CHB ; 5 . Surgery allow ; 6 . Informed consent patient . 1 . Patient chronic hepatopathy , AIH , NAFLD , ALD ; 2 . Serious problem heart , lung , kidney severe dysfunction ; 3 . Pregnant child breast feeding woman ; 4 . Mental cognitive disorder ; 5 . Participating drug trial ; 6. Who allergic study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>